Japan To Rule On Iressa Deaths; Government Cleared
This article was originally published in PharmAsia News
Japan's Supreme Court agreed to consider an appeal brought by families seeking damages from AstraZeneca KK, which imported the Iressa (gefitinib) lung cancer drug from its parent, the UK's AstraZeneca.
You may also be interested in...
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.